Takumi Aoki

Kawagoe, 3508550, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Early risk stratification in lupus nephritis based on established prognostic factors: association with outcomes under triple therapy.

Early risk stratification in lupus nephritis based on established prognostic factors: association with outcomes under triple therapy.

Journal: Arthritis research & therapy

Published: June 11, 2026

Takayasu and Giant Cell Arteritis Unmasked by Vedolizumab as Paradoxical Reactions: Two Case Reports.

Takayasu and Giant Cell Arteritis Unmasked by Vedolizumab as Paradoxical Reactions: Two Case Reports.

Journal: ACR open rheumatology

Published: January 31, 2026

Perspective of the Pharmaceuticals and Medical Devices Agency on Drug Development for Childhood Myopia.

Perspective of the Pharmaceuticals and Medical Devices Agency on Drug Development for Childhood Myopia.

Journal: Clinical pharmacology and therapeutics

Published: June 07, 2025

Chronic kidney disease and inflammatory cytokines in rheumatoid arthritis: a potential pathogenic link.

Chronic kidney disease and inflammatory cytokines in rheumatoid arthritis: a potential pathogenic link.

Journal: Immunological medicine

Published: January 31, 2025

Discovery of orally bioavailable inhibitors of MALT1 with in vivo activity for psoriasis.

Discovery of orally bioavailable inhibitors of MALT1 with in vivo activity for psoriasis.

Journal: Bioorganic & medicinal chemistry letters

Published: December 20, 2022

Structure-activity relationship studies of 3-substituted pyrazoles as novel allosteric inhibitors of MALT1 protease.

Structure-activity relationship studies of 3-substituted pyrazoles as novel allosteric inhibitors of MALT1 protease.

Journal: Bioorganic & medicinal chemistry letters

Published: January 18, 2021

Comparison of quadriceps setting strength and knee extension strength tests to evaluate lower limb muscle strength based on health-related physical fitness values in elderly people.

Comparison of quadriceps setting strength and knee extension strength tests to evaluate lower limb muscle strength based on health-related physical fitness values in elderly people.

Journal: BMJ open sport & exercise medicine

Published: June 11, 2020

Multiple binding modes of a small molecule to human Keap1 revealed by X-ray crystallography and molecular dynamics simulation.

Multiple binding modes of a small molecule to human Keap1 revealed by X-ray crystallography and molecular dynamics simulation.

Journal: FEBS open bio

Published: May 21, 2015

A novel MitoNEET ligand, TT01001, improves diabetes and ameliorates mitochondrial function in db/db mice.

A novel MitoNEET ligand, TT01001, improves diabetes and ameliorates mitochondrial function in db/db mice.

Journal: The Journal of pharmacology and experimental therapeutics

Published: December 16, 2014

Discovery of 1-oxa-4,9-diazaspiro[5.5]undecane-based trisubstituted urea derivatives as highly potent soluble epoxide hydrolase inhibitors and orally active drug candidates for treating of chronic kidney diseases.

Discovery of 1-oxa-4,9-diazaspiro[5.5]undecane-based trisubstituted urea derivatives as highly potent soluble epoxide hydrolase inhibitors and orally active drug candidates for treating of chronic kidney diseases.

Journal: Bioorganic & medicinal chemistry letters

Published: September 12, 2013

Nrf2 activators attenuate the progression of nonalcoholic steatohepatitis-related fibrosis in a dietary rat model.

Nrf2 activators attenuate the progression of nonalcoholic steatohepatitis-related fibrosis in a dietary rat model.

Journal: Molecular pharmacology

Published: April 18, 2013

Discovery of 2,8-diazaspiro[4.5]decane-based trisubstituted urea derivatives as highly potent soluble epoxide hydrolase inhibitors and orally active drug candidates for treating hypertension.

Discovery of 2,8-diazaspiro[4.5]decane-based trisubstituted urea derivatives as highly potent soluble epoxide hydrolase inhibitors and orally active drug candidates for treating hypertension.

Journal: Bioorganic & medicinal chemistry letters

Published: April 17, 2013

Showing 1-12 of 15

Last Updated: 09/26/2026